Listed by the USPTO as DAHLIN, HEATHER RAQUEL
Tech Center 1600 • Art Units: 1628 1629
This examiner grants 42% of resolved cases
DAHLIN, HEATHER RAQUEL is a Tech Center 1600 examiner in Art Unit 1628 with 166 resolved cases. The allowance rate is 42.2%, and the median time to allowance is 1229 days. The profile supports deliberate prosecution planning, with attention to both claim development and the time required to reach allowance.
The interview lift is 47.1%, indicating a positive association with interview activity. Practitioners may find value in using interviews to isolate the examiner’s concerns before committing to a particular amendment strategy.
Orcosa Inc., Hoffmann-La Roche Inc., and King's College London are the listed companies. OLIFF PLC, PATTERSON + SHERIDAN, L.L.P., and TROUTMAN PEPPER LOCKE LLP are the listed firms with experience reflected in the profile.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18023211 | KAEMPFEROL AGLYCONE-CONTAINING EXTRACT | Final Rejection | OTSUKA PHARMACEUTICAL CO., LTD. |
| 18265335 | COMPOSITIONS AND METHODS FOR INHIBITING M PRO PROTEASE ACTIVITY AND FOR PREVENTING AND TREATING SARS-COV-2 INFECTION | Final Rejection | Arizona Board of Regents on Behalf of the University of Arizona |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy42.2% of resolved applications examined by Heather Raquel Dahlin were allowed (166 resolved cases), compared with 26.0% across Art Unit 1628 over the last five years.
This examiner's interview lift is +47.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Heather Raquel Dahlin took 1,229 days on average from filing to allowance.
Heather Raquel Dahlin examines applications in Art Unit 1628 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
